Alvotech
Ticker
ALVO.IC
ISIN
LU2458332611
Price
ISK 1,865.00
Change Today
-5.00 / -0.267 %
Price 1 year ago
1,280.00 / 45.703 %
Market Capitalization
-
52 Week Low
958.00
52 Week High
2,450.00
200 Day Moving Average
1,602.98
50-day Moving Average
1,927.80
Price evolution
Yearly Returns
Peers
Peers
Company information
Summary
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT04, a biosimilar to Stelara to treat various inflammatory conditions comprising psoriatic arthritis, Crohn's disease, ulcerative colitis, plaque psoriasis, and other indications; AVT06, a biosimilar to Eylea to treat various conditions, such as age-related macular degeneration, macular edema, and diabetic retinopathy; and AVT03, a biosimilar to Xgeva and Prolia, which is in the pre-clinical phase to treat prevent bone fracture, spinal cord compression, and the need for radiation or bone surgery in patients with certain types of cancer, as well as prevent bone loss and increase bone mass. It also offers AVT05, a biosimilar to Simponi and Simponi Aria, which is in early phase development to treat various inflammatory conditions, including, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and other indications; AVT23, a biosimilar to Xolair, which is in late-stage development to treat nasal polyps; AVT16, a biosimilar to an immunology product; and AVT33, a biosimilar to an oncology product. The company was founded in 2013 and is headquartered in Reykjavik, Iceland.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
Iceland
Exchange
ICE
Earnings Per Share
-
P/E Ratio
-
Debt/Equity Ratio
-
Beta
-
Ebitda
-220,464,992.00
-
Enterprise to Ebitda
-67.51
Enterprise Value
14,883,906,560.00
Target Price
-
Estimated Price
-
Book Value
-
Expected Growth
-
Balance sheet
Income statement
Sustainability
Correlation
Company | Name | Correlation |
---|---|---|
0460.HK | SIHUAN PHARM | -0.32 |
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | -0.23 |
300199.SZ | HYBIO PHARMACEUTIC | -0.21 |
300026.SZ | TIANJIN CHASE SUN | -0.19 |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | -0.18 |
300039.SZ | SHANGHAI KAIBAO PH | -0.16 |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | -0.15 |
HLN.L | HALEON PLC | -0.14 |
SIDO.JK | Industri Jamu dan Farmasi Sido | -0.13 |
300534.SZ | GANSU LONGSHENRONG | -0.12 |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | -0.10 |
300239.SZ | BAOTOU DONGBAO BIO | -0.04 |
300158.SZ | SHANXI ZHENDONG PH | -0.04 |
600277.SS | ELION CLEAN ENERGY CO LTD | 0.01 |
300110.SZ | HUAREN PHARMACEUTI | 0.02 |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | 0.03 |
0570.HK | TRAD CHI MED | 0.08 |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | 0.11 |
300194.SZ | FUAN PHARMACEUTICA | 0.11 |
300142.SZ | WALVAX BIOTECHNOLO | 0.11 |
MCOA | MARIJUANA COMPANY OF AMERICA IN | 0.12 |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | 0.13 |
SFLM | SFLMAVEN CORP | 0.15 |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | 0.17 |
TEVA | Teva Pharmaceutical Industries | 0.21 |
600216.SS | ZHEJIANG MEDICINE | 0.25 |
002001.SZ | ZHEJIANG NHU CO | 0.34 |
TLRY | Tilray Brands, Inc. - Class 2 | 0.36 |
Similar companies
Ticker | Name | City | Country | Currency | Exchange | Beta | EV/EBITDA | Employees | Site |
---|---|---|---|---|---|---|---|---|---|
MCOA | MARIJUANA COMPANY OF AMERICA IN | Los Angeles | United States | USD | PNK | 1.15 | -1.91 | 7 | https://www.marijuanacompanyofamerica.com |
600277.SS | ELION CLEAN ENERGY CO LTD | Beijing | China | CNY | SHH | 0.81 | 14.08 | 3926 | https://www.elion.cn |
300026.SZ | TIANJIN CHASE SUN | Tianjin | China | CNY | SHZ | -0.10 | 16.16 | https://www.chasesun.cn | |
ENDP | Endo International plc | Dublin | Ireland | USD | NMS | 1.12 | 9.59 | 3103 | https://www.endo.com |
300110.SZ | HUAREN PHARMACEUTI | Qingdao | China | CNY | SHZ | 0.86 | 22.14 | 2242 | https://www.qdhuaren.com |
600518.SS | KANGMEI PHARMACEUTICAL CO LTD | Puning | China | CNY | SHH | 0.26 | -11.18 | 6410 | https://www.kangmei.com.cn |
600062.SS | CHINA RESOURCES DOUBLE-CRANE PH | Beijing | China | CNY | SHH | -0.16 | 12.21 | 11029 | https://www.dcpc.com |
600079.SS | HUMANWELL HEALTHCARE (GROUP) CO | Wuhan | China | CNY | SHH | 0.87 | 13.32 | 15746 | https://www.humanwell.com.cn |
SIDO.JK | Industri Jamu dan Farmasi Sido | Semarang | Indonesia | IDR | JKT | 0.14 | 15.04 | 3081 | https://www.sidomuncul.co.id |
600196.SS | SHANGHAI FOSUN PHARMACEUTICAL G | Shanghai | China | CNY | SHH | 0.65 | 30.59 | 36279 | https://www.fosunpharma.com |
HLN.L | HALEON PLC | Weybridge | United Kingdom | GBp | LSE | 16.31 | 22000 | https://www.haleon.com | |
002001.SZ | ZHEJIANG NHU CO | Xinchang | China | CNY | SHZ | 0.31 | 10.45 | 10805 | https://www.cnhu.com |
0460.HK | SIHUAN PHARM | Wan Chai | Hong Kong | HKD | HKG | 0.61 | 7.15 | 4282 | https://www.sihuanpharm.com |
TLRY | Tilray Brands, Inc. - Class 2 | Leamington | Canada | USD | NMS | -28.58 | https://www.tilray.com | ||
300199.SZ | HYBIO PHARMACEUTIC | Shenzhen | China | CNY | SHZ | 0.02 | -117.98 | 885 | https://www.hybio.com.cn |
0570.HK | TRAD CHI MED | Wan Chai | Hong Kong | HKD | HKG | 0.51 | 5.97 | 17098 | https://www.china-tcm.com.cn |
600216.SS | ZHEJIANG MEDICINE | Shaoxing | China | CNY | SHH | -0.16 | 7.75 | 5901 | https://www.zmc.top |
300194.SZ | FUAN PHARMACEUTICA | Chongqing | China | CNY | SHZ | 0.41 | 15.82 | 3004 | https://www.fapharm.com |
300039.SZ | SHANGHAI KAIBAO PH | Shanghai | China | CNY | SHZ | 0.31 | 32.28 | 1432 | https://www.xykb.com |
300142.SZ | WALVAX BIOTECHNOLO | Kunming | China | CNY | SHZ | 0.62 | 56.64 | https://www.walvax.com | |
300239.SZ | BAOTOU DONGBAO BIO | Baotou | China | CNY | SHZ | 0.26 | 43.88 | 1354 | https://www.dongbaoshengwu.com |
600252.SS | GUANGXI WUZHOU ZHONGHENG GROUP | Wuzhou | China | CNY | SHH | 0.39 | 56.88 | 3453 | https://www.wz-zhongheng.com |
300158.SZ | SHANXI ZHENDONG PH | Changzhi | China | CNY | SHZ | 0.32 | 5.06 | 4123 | https://www.zdjt.com |
600781.SS | FUREN GROUP PHARMACEUTICAL CO L | Shanghai | China | CNY | SHH | 0.27 | -5.14 | 2916 | https://www.shfuren.cn |
ZOM | Zomedica Corp. | Ann Arbor | United States | USD | ASE | 0.59 | -3.10 | 47 | https://www.zomedica.com |
300534.SZ | GANSU LONGSHENRONG | Lanzhou | China | CNY | SHZ | 0.38 | 195.38 | 302 | https://www.lsrfzy.com |
SFLM | SFLMAVEN CORP | Leamington Spa | United Kingdom | USD | PNK | 3.15 | -1.48 | 1 | https://www.dnadynamicsinc.com |
600750.SS | JIANGXI JIANGZHONG PHARMACEUTIC | Nanchang | China | CNY | SHH | 0.40 | 9.25 | 4153 | https://www.jzjt.com |
600380.SS | JOINCARE PHARMACEUTICAL GROUP I | Shenzhen | China | CNY | SHH | 0.66 | 6.07 | 13234 | https://www.joincare.com |
TEVA | Teva Pharmaceutical Industries | Tel Aviv | Israel | USD | NYQ | 1.22 | 7.45 | 34713 | https://www.tevapharm.com |
600521.SS | ZHEJIANG HUAHAI PHARMACEUTICAL | Linhai | China | CNY | SHH | 0.22 | 30.80 | 7019 | https://www.huahaipharm.com |
600664.SS | HARBIN PHARMACEUTICAL GROUP CO | Harbin | China | CNY | SHH | 9.55 | https://www.hayao.com | ||
300401.SZ | ZHEJIANG GARDEN BI | Dongyang | China | CNY | SHZ | -0.24 | 14.95 | 742 | https://www.hybiotech.com |
600568.SS | ZHONG ZHU HEALTHCARE HOLDING CO | Zhuhai | China | CNY | SHH | 0.45 | -231.66 | 1286 | https://www.zz600568.com |
CGC | Canopy Growth Corporation | Smiths Falls | Canada | USD | NMS | 2.23 | -2.61 | 3151 | https://www.canopygrowth.com |
DVLP | GOLDEN DEVELOPING SOLUTIONS INC | Fort Lauderdale | United States | USD | PNK | 1.60 | https://goldendeveloping.com | ||
SIGA | SIGA Technologies Inc. | New York | United States | USD | NGM | 0.40 | 12.13 | 39 | https://www.siga.com |
3320.HK | CHINARES PHARMA | Wan Chai | Hong Kong | HKD | HKG | 0.42 | 9.52 | 65000 | https://www.crpharm.com |
300601.SZ | SHENZHEN KANGTAI B | Shenzhen | China | CNY | SHZ | 0.31 | 17.71 | 2445 | https://www.biokangtai.com |
600267.SS | ZHEJIANG HISUN PHARMACEUTICAL C | Taizhou | China | CNY | SHH | 0.53 | 11.17 | 8280 | https://www.hisunpharm.com |
Funds
Mutual Fund Holders
Social
Dividends
Ratings
News
Earnings
SEC Filings
Options
Indicators
Glossary
- Momentum
- A technical indicator that measures the rate of change in price movements over a specific period. It indicates the strength or weakness of a price trend.
Assessment: A positive momentum value generally indicates a good trend, while a negative value suggests a weak or downward trend.
- Inertia
- In trading, inertia refers to the tendency of prices to continue moving in their current direction. It suggests that an asset's price will likely maintain its current trend.
Assessment: A higher inertia value is generally considered good, as it indicates a strong and sustained price trend.
- Relative Strength Index (RSI)
- A momentum oscillator that measures the speed and change of price movements. It helps identify overbought or oversold conditions in an asset.
Assessment: An RSI value above 70 is typically considered overbought and may suggest a potential reversal or correction. Conversely, an RSI value below 30 is often considered oversold, indicating a possible upward price correction.
- Fibonacci's Weighted Moving Average
- A technical indicator that assigns different weights to recent data points, giving more significance to recent prices. It helps smooth out price fluctuations and identify trend reversals.
Assessment: The interpretation of the Fibonacci's Weighted Moving Average value depends on its comparison to other moving averages or trendlines. A value above 50 may indicate an uptrend, while a value below 50 may suggest a downtrend.
- Williams %R
- A momentum indicator that measures overbought or oversold conditions in an asset. It shows the relationship of the current closing price to the high-low range over a specified period.
Assessment: Williams %R values above -20 are typically considered overbought and may indicate a potential price reversal. Values below -80 are often viewed as oversold, suggesting a potential price bounce.
- Relative Volatility Index (RVI)
- A technical indicator that measures the volatility of a security by comparing the magnitude of recent price movements to the magnitude of average price changes. It helps identify periods of high or low volatility.
Assessment: A higher RVI value suggests higher volatility, which can provide trading opportunities but also carries increased risk.
- Commodity Channel Index (CCI)
- A versatile indicator that measures the current price level relative to an average price level over a given period. It helps identify overbought or oversold conditions and potential trend reversals.
Assessment: CCI values above 100 are often considered overbought, indicating a potential price correction or reversal. Values below -100 are typically viewed as oversold, suggesting a potential price rebound.